Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
194M
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
1.58M
-
Shares change
-
+87.8K
-
Total reported value, excl. options
-
$152M
-
Value change
-
+$8.47M
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$96.42
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q4 2023
8 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q4 2023.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.58M shares
of 194M outstanding shares and own 0.81% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (18.4M shares), VANGUARD GROUP INC (18.1M shares), BlackRock Inc. (14.7M shares), Dodge & Cox (14M shares), Capital Research Global Investors (10.8M shares), STATE STREET CORP (6.73M shares), AMERIPRISE FINANCIAL INC (5.42M shares), BARCLAYS PLC (5.29M shares), VIKING GLOBAL INVESTORS LP (4.89M shares), and Avoro Capital Advisors LLC (4.3M shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.